- Home
- TBLA vs NEO Comparison
TBLA vs NEO Comparison
Compare TBLA & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TBLA
- NEO
- Stock Information
- Founded
- TBLA 2007
- NEO 2001
- Country
- TBLA United States
- NEO United States
- Employees
- TBLA N/A
- NEO N/A
- Industry
- TBLA Computer Software: Programming Data Processing
- NEO Precision Instruments
- Sector
- TBLA Technology
- NEO Health Care
- Exchange
- TBLA Nasdaq
- NEO Nasdaq
- Market Cap
- TBLA 991.0M
- NEO 1.1B
- IPO Year
- TBLA N/A
- NEO 1999
- Fundamental
- Price
- TBLA $3.37
- NEO $7.98
- Analyst Decision
- TBLA Strong Buy
- NEO Buy
- Analyst Count
- TBLA 5
- NEO 9
- Target Price
- TBLA $4.50
- NEO $12.63
- AVG Volume (30 Days)
- TBLA 1.3M
- NEO 2.6M
- Earning Date
- TBLA 11-06-2025
- NEO 11-04-2025
- Dividend Yield
- TBLA N/A
- NEO N/A
- EPS Growth
- TBLA N/A
- NEO N/A
- EPS
- TBLA 0.04
- NEO N/A
- Revenue
- TBLA $1,817,019,000.00
- NEO $689,189,000.00
- Revenue This Year
- TBLA $8.20
- NEO $10.40
- Revenue Next Year
- TBLA $4.60
- NEO $10.11
- P/E Ratio
- TBLA $83.09
- NEO N/A
- Revenue Growth
- TBLA 12.01
- NEO 9.70
- 52 Week Low
- TBLA $2.50
- NEO $4.72
- 52 Week High
- TBLA $4.30
- NEO $19.12
- Technical
- Relative Strength Index (RSI)
- TBLA 51.98
- NEO 63.99
- Support Level
- TBLA $3.32
- NEO $7.84
- Resistance Level
- TBLA $3.39
- NEO $9.06
- Average True Range (ATR)
- TBLA 0.08
- NEO 0.38
- MACD
- TBLA 0.01
- NEO 0.21
- Stochastic Oscillator
- TBLA 72.34
- NEO 65.38
About TBLA Taboola.com Ltd.
Taboola.com Ltd is a technology company that powers recommendations across the Open Web with an artificial intelligence-based, algorithmic engine. It partners with websites, devices, and mobile apps, collectively referred to as digital properties, to recommend editorial content and advertisements on the Open Web. Geographically it serves Israel, the United Kingdom, United States, Germany, Rest of the world. It generates the majority of its revenue from the United States.
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.